drug · vaccine component
patient view →pneumococcal polysaccharide [21-valent] vaccine
pre_registrationupdated 2mo agoby $MRK Merck & Co., Inc.🔗 ChEMBL
community read0 votes
Vaccine component drug with a maximum clinical stage of Approval (across all indications), with an approval for pneumococcal infection and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that